Research Article
Microbiologic Spectrum and Antibiotic Susceptibility Pattern among Patients with Urinary and Respiratory Tract Infection
Table 5
Antimicrobial susceptibility pattern of isolated organisms from sputum.
| | Organism | Type of antibiotic | Susceptibility level | | Susceptible | Intermediate | Resistant |
| | Staphylococcus aureus | Vancomycin | 55 (100%) | 0 (0%) | 0 (0%) | | Clindamycin | 11 (25.6%) | 0 (0%) | 32 (74.4%) | | Ciprofloxacin | 8 (24.2%) | 12 (36.4%) | 13 (39.4%) | | Erythromycin | 8 (15.4%) | 0 (0%) | 44 (84.6%) | | Gentamicin | 4 (13.3%) | 3 (10%) | 23 (76.7%) | | Cotrimoxazole | 46 (90.2%) | 0 (0%) | 5 (9.8%) | | Cefoxitin | 7 (13.3%) | 2 (3.8%) | 43 (82.7%) |
| | Acinetobacter | Imipenem | 36 (50.7%) | 1 (1.4%) | 34 (47.9%) | | Meropenem | 8 (17.8%) | 2 (4.4%) | 35 (77.8%) | | Gentamicin | 11 (15.9%) | 1 (1.4%) | 57 (82.6%) | | Tobramycin | 6 (14.3%) | 2 (4.8%) | 34 (81%) | | Ciprofloxacin | 10 (14.1%) | 7 (9.9%) | 54 (79.1%) | | Amikacin | 7 (10.4%) | 2 (3%) | 58 (86.6%) | | Cotrimoxazole | 5 (9.3%) | 0 (0%) | 49 (90.7%) | | Ceftazidime | 5 (7.4%) | 1 (1.5%) | 62 (91.2%) | | Ceftriaxone | 2 (3.2%) | 3 (4.8%) | 58 (92.1%) |
| | Pseudomonas aeruginosa | Meropenem | 19 (90.5%) | 1 (4.8%) | 1 (4.8%) | | Ciprofloxacin | 49 (87.5%) | 4 (7.1%) | 3 (5.4%) | | Imipenem | 54 (84.4%) | 4 (6.3%) | 6 (9.4%) | | Amikacin | 47 (73.4%) | 5 (7.8%) | 12 (18.8%) | | Gentamicin | 41 (67.2%) | 1 (1.6%) | 19 (31.1%) | | Tobramycin | 36 (66.7%) | 2 (3.7%) | 16 (29.6%) | | Ceftazidime | 21 (34.4%) | 1 (1.6%) | 39 (63.9%) |
|
|
